Novo Nordisk A/S (NVO) Operating Income 2006–TTM

Name: Novo Nordisk A/S (NVO) operating income history 2006-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Novo Nordisk A/S annual operating income for fiscal TTM was DKK 142.1 billion, an increase of 11.3% from DKK 127.7 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

NVO Annual Operating Income

Operating Income (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Operating Income (EBIT)	DKK 142.1B	DKK 127.7B	DKK 128.3B	DKK 102.6B	DKK 74.8B	DKK 58.6B	DKK 54.1B	DKK 52.5B	DKK 47.2B	DKK 49.0B	DKK 48.4B	DKK 49.4B	DKK 34.5B	DKK 31.5B	DKK 29.5B	DKK 22.4B	DKK 18.9B	DKK 14.9B	DKK 12.4B	DKK 9.0B	DKK 9.1B

DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NVO Quarterly Operating Income

Operating Income (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Operating Income (EBIT)	DKK 27.1B	DKK 59.6B	DKK 31.7B	DKK 23.7B	DKK 33.4B	DKK 38.8B	DKK 36.7B	DKK 33.8B	DKK 25.9B

DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Operating Income at Comparable Companies

NVS Operating Income — Novartis AG ADR
AZN Operating Income — AstraZeneca PLC

More NVO metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All NVO financial statements → Interactive NVO charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.